Bristol/Pfizer clot preventer delayed in U.S.

June 25 (Reuters) - A closely watched blood clot preventer
from Bristol-Myers Squibb Co and Pfizer Inc has
failed to win approval from U.S. health regulators, the
companies said on Monday.

furniture for cabins country cottage desk portable shower rentals